{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:43:22Z","timestamp":1792082602010,"version":"4.4.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Transcatheter aortic valve replacement (TAVR) has established itself as a safe and efficient treatment option in patients with severe aortic valve stenosis, regardless of the underlying surgical risk. Widespread adoption of transfemoral procedures led to more patients than ever being eligible for TAVR. This increase in procedural volumes has also stimulated the use of vascular closure devices (VCDs) for improved access site management. In a single-center examination, we investigated 871 patients that underwent transfemoral TAVR from 2010 to 2020 and assessed vascular complications according to the Valve Academic Research Consortium (VARC) III recommendations. Patients were grouped by the VCD and both, vascular closure success and need for intervention were analyzed. In case of a vascular complication, the type of intervention was investigated for all VCDs. The Proglide VCD was the most frequently used device (<jats:italic>n<\/jats:italic> = 670), followed by the Prostar device (<jats:italic>n<\/jats:italic> = 112). Patients were old (median age 83 years) and patients suffered from high comorbidity burden (60% coronary artery disease, 30% type II diabetes, 40% atrial fibrillation). The overall rate of major complications amounted to 4.6%, it was highest in the Prostar group (9.6%) and lowest in the Manta VCD group (1.1% <jats:italic>p<\/jats:italic> = 0.019). The most frequent vascular complications were bleeding and hematoma (<jats:italic>n<\/jats:italic> = 110, 13%). In case a complication occurred, 72% of patients did not need any further intervention other than manual compression or pressure bandages. The rate of surgical intervention after complication was highest in the Prostar group (<jats:italic>n<\/jats:italic> = 15, 29%, <jats:italic>p<\/jats:italic> = 0.001). Temporal trends in VCD usage highlight the rapid adoption of the Proglide system after introduction at our institution. In recent years VCD alternatives, utilizing other closure techniques, such as the Manta device emerged and increased vascular access site management options. This 10-year single-center experience demonstrates high success rates for all VCDs. Despite successful closure, a significant number of patients does experience minor vascular complications, in particular bleeding and hematoma. However, most complications do not require surgical or endovascular intervention. Temporal trends display a marked increase in TAVR procedures and highlight the need for more refined vascular access management strategies.<\/jats:p>","DOI":"10.3389\/fcvm.2021.791693","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T06:17:58Z","timestamp":1642745878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Gregor","family":"Heitzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Koschatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varius","family":"Dannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Mascherbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya","family":"Halavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Don\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Koschutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Spinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Loewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Neumayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gschwandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Willfort-Ehringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max-Paul","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Bartko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Goliasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","article-title":"Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description","volume":"106","author":"Cribier","year":"2002","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.athoracsur.2020.09.002","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement","volume":"111","author":"Carroll","year":"2021","journal-title":"Ann Thorac Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/eurheartj\/ehaa048","article-title":"GARY-the largest registry of aortic stenosis treatment worldwide","volume":"41","author":"Hamm","year":"2020","journal-title":"Eur Heart J."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","author":"Vahanian","year":"2021","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"Varc-3 Writing","year":"2021","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jvs.2018.05.019","article-title":"A systematic review of vascular closure devices for femoral artery puncture sites","volume":"68","author":"Noori","year":"2018","journal-title":"J Vasc Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ccd.25130","article-title":"Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure","volume":"84","author":"Nakamura","year":"2014","journal-title":"Catheter Cardiovasc Interv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e007258","DOI":"10.1161\/CIRCINTERVENTIONS.119.007258","article-title":"Pivotal clinical study to evaluate the safety and effectiveness of the manta percutaneous vascular closure device","volume":"12","author":"Wood","year":"2019","journal-title":"Circ Cardiovasc Interv."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.4244\/EIJV12I10A213","article-title":"One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation","volume":"12","author":"Mehilli","year":"2016","journal-title":"EuroIntervention."},{"key":"B13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jcin.2013.04.003","article-title":"Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes","volume":"6","author":"Toggweiler","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/152660289900600209","article-title":"Closure of large percutaneous access sites using the prostar XL percutaneous vascular surgery device","volume":"6","author":"Haas","year":"1999","journal-title":"J Endovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"E734","DOI":"10.1002\/ccd.25053","article-title":"Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation","volume":"82","author":"Griese","year":"2013","journal-title":"Catheter Cardiovasc Interv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4244\/EIJV11I6A137","article-title":"Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation","volume":"11","author":"Barbanti","year":"2015","journal-title":"EuroIntervention."},{"key":"B17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ijcard.2016.08.193","article-title":"Impact of suture mediated femoral access site closure with the prostar XL compared to the proglide system on outcome in transfemoral aortic valve implantation","volume":"223","author":"Seeger","year":"2016","journal-title":"Int J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e018042","DOI":"10.1161\/JAHA.120.018042","article-title":"Efficacy and safety of proglide versus prostar XL vascular closure devices in transcatheter aortic valve replacement: the RISPEVA registry","volume":"9","author":"Berti","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1558","DOI":"10.4244\/EIJ-D-18-00769","article-title":"Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus proglide","volume":"14","author":"Moriyama","year":"2019","journal-title":"EuroIntervention."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057856","article-title":"Comparison of a pure plug-based versus a primary suture-based vascular closure device strategy for transfemoral transcatheter aortic valve replacement: the CHOICE-CLOSURE randomized clinical trial","author":"Abdel-Wahab","year":"2021","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.amjcard.2012.06.042","article-title":"Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation","volume":"110","author":"Van Mieghem","year":"2012","journal-title":"Am J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.amjcard.2016.07.045","article-title":"Frequency and effect of access-related vascular injury and subsequent vascular intervention after transcatheter aortic valve replacement","volume":"118","author":"Dencker","year":"2016","journal-title":"Am J Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1538574419879568","article-title":"Predictors of groin access pseudoaneurysm complication: a 10-year institutional experience","volume":"54","author":"Naddaf","year":"2020","journal-title":"Vasc Endovascular Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ccd.29095","article-title":"Access site related vascular complications with third generation transcatheter heart valve systems","volume":"97","author":"Ruge","year":"2021","journal-title":"Catheter Cardiovasc Interv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jcin.2011.03.019","article-title":"Transfemoral aortic valve implantation new criteria to predict vascular complications","volume":"4","author":"Hayashida","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.carrev.2020.01.007","article-title":"Incidence, prognosis and predictors of major vascular complications and percutaneous closure device failure following contemporary percutaneous transfemoral transcatheter aortic valve replacement","volume":"21","author":"Batchelor","year":"2020","journal-title":"Cardiovasc Revasc Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.791693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T06:18:00Z","timestamp":1642745880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.791693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2021.791693"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.791693","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"791693"}}